
DSPA
Nom chimique
sodium [(2R)-2,3-di(octadecanoyloxy)propyl] hydrogen phosphate
DSPA•LNP
Structure: 

N° produit
CH51044
CAS
108321-18-2
FM
C39H76NaO8P
PM
726.98
Spécification
| Catalog No. | CH51044 |
| CAS No. | 108321-18-2 |
| Molecular Formula | C39H76NaO8P |
| Molecular Weight | 726.98 |
CHEMOS Support for This Category
CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.
Vue d’ensemble
DSPA (also known as sodium [(2R)-2,3-di(octadecanoyloxy)propyl] hydrogen phosphate) (CAS 108321-18-2, MF C39H76NaO8P, MW 726.98) is a delivery-system formulation component of interest to liposomal and LNP research. Typical chemistry topics include identity confirmation, route consistency, and impurity control. Custom synthesis, process scale-up and supply planning are available through CHEMOS R&D and manufacturing facilities.
Applications
- DSPA (CAS 108321-18-2) route review and custom analog preparation
- Reference material for delivery-system composition studies
- Custom synthesis and analog preparation for delivery research
Besoin d’une synthèse à façon ?
Notre équipe CDMO accompagne la synthèse à façon, de l’évaluation de voie au développement de procédé et au scale-up.
Voir les services CDMO